Difference between revisions of "Favorite Journals"

Revision as of 07:58, 20 June 2025

Journal name (IF 2013 - 2016) (2016JCR top%)

Weekly press

• Nature (49.962, 69.504, 64.8, 50.5, 48.5)(98.9%)
• Science (47.238, 63.798. 56.9, 44.7, 45.8)(98.1%)

Biweekly press

• Cell (41.582, 66.850, 64.5, 45.5, 42.5)(99.2%)
• Nucleic Acids Research (16.971, 19.160, 14.9, 16.6, 13.1)(96.1%)**
• Clinical Cancer Research by AACR (12.531, 13.801, 11.5, 10.0, 10.2)(91.3%)
• Cancer Research by AACR (12.701, 13.312, 11.2, 12.5, 16.6)(95.2%)**

Monthly press

- Every first week of the month

• Nature Reviews Drug Discovery
• Nature Reviews Cancer
• Nature Reviews Immunology
• Nature Reviews Microbiology
• Nature Reviews Genetics
• Nature Reviews Gastroenterology & Hepatology
• Cancer Discovery by AACR (29.497, 39.397, 38.272, 28.2, 29.7)(97.7%)
• Gastroenterology(17.373, 22.682, 33.883, 29.4, 25.7)(97.6%)
• GUT(19.819, 23.059, 31.840, 24.5, 23.0)(96.9%)
• Journal of Hepatology(20.582, 25.083, 30.083, 25.7, 26.8)(98.3%)
• Hepatology(14.679, 17.425, 17.298, 13.5, 12.9)(95.5%)
• Cancer Communications(5.627, 10.391, 15.253, 16.2, 20.1)(95.8%)**
• Journal for ImmunoTherapy of Cancer (9.913,13.751, 12.487, 10.9, 10.3)(93.6%)**
• Cancer Immunology Research by AACR (8.728, 11.151, 12.020, 10.1, 8.1)(89.3%)

- Online publication (but check once per month)

• Genome Biology (10.806, 13.583, 18.011, 12.3, 10.1)(95.7%)**
• Microbiome(11.607, 14.650, 16.837, 15.5, 13.8)(95.3%)**
• Animal Microbiome(-, -, -, 4.7, 4.9)(97.3%)
• Nature Communications (12.121, 14.919, 17.694, 16.6, 14.7)(94.4%)**
• Genome Medicine (10.675, 11.117, 15.266, 12.3, 10.4)(95.5%)**
• Molecular Systems Biology (8.991, 11.429, 13.068. 9.9, 8.5)(90.6%)
• Gut Microbes (10.245, 9.434, 12.2, 12.2, 11.0)(94.2%)**
• npj Biofilms and Microbiomes(7.067, 7.290, 8.462, 9.2, 7.8)(91.7%)
• Computers in Biology and Medicine(3.434, 4.589, 6.698, 7.7, 7.0)(97.7%)**
• Journal of Experimental & Clinical Cancer Research(7.068, 11.161, 12.658, 11.3, 11.4)(92.4%)

- Every second week of the month

• Nature Biotechnology (31.864, 36.558, 54.908, 46.9, 33.1)(99.1%)
• Nature Genetics (27.603, 38.330, 41.379, 30.8, 31.7)(99.2%)
• Nature Methods (30.822, 28.547, 47.990, 48.0, 36.1)(99.4%)
• Nature Immunology (20.479, 25.606, 31.250, 30.5, 27.7)(99.2%)
• Nature Microbiology (15.540, 17.745, 30.964, 28.3, 20.5)(97.2%)
• Nature Protocols (10.419, 13.491, 17.021, 14.8, 13.1)(98.2%)
• Nature Aging (-. -. -. 16.6, 17.0)(99.3%)**
• Cell Metabolism(21.567, 27.287, 31.373, 29.0, 27.7)(98.7%)
• Science Translational Medicine (16.304, 17.956, 19.359, 17.1, 15.8)(99.2%)
• Science Immunology (13.440, 17.727, 30.663, 24.8, 17.6)(97.0%)
• Science Advances (13.116, 14.136, 14.972, 13.6, 11.7)(92.2%)**
• Clinical and Translational Medicine (7.919, 11.492, 8.554, 10.6, 7.9)(90.7%)
• Cell Genomics (-, -, -, -, 11.1)(96.6%)**(ESCI)

- Every third week of the month

• Nature Medicine (53.440, 68.164, 87.241, 82.9, 58.7) (99.8%)
• Immunity (22.553, 31.745, 43.474, 32.4, 25.5)(98.1%)
• Cancer Cell (26.602, 31.743, 38.585, 50.3, 48.8) (98.8%)
• Cell Host and Microbe (15.923, 21.023, 31.316, 30.3, 20.6)(98.9%)
• Patterns (-, -, -, 6.5, 6.7)(89.8%)(ESCI)
• Med By Cell(-, -, -, 17.0, 12.8)(97.6%)(ESCI)

- Every last week of the month

• Nature Machine Intelligence (-, 15.508, 25.898, 23.8, 18.8) (99.7%)**
• Nature Metabolism (-, 13.511, 19.950, 20.8, 18.9)(97.6%)
• Nature Cancer (-, -, 23.177, 22.7, 23.5)(96.7%)
• Cell Reports Medicine (-, -, 16.988, 14.3, 11.7) (95.0%)**
• Cell Systems (8.673, 10.304, 11.091, 9.3, 9.0)(91.2%)
• Genome Research (11.093, 9.043, 9.438, 7.0, 6.2)(88.2%)
• Cell Reports (8.109, 9.413, 9.995, 8.8, 7.5)(82.7%)
• Cell Reports Methods(-, -, -, 3.8, 4.3)(86.5%) (ESCI)
• Experimental & Molecular Medicine(5.418, 8.718, 12.178, 12.8, 9.5)(93.4%)**
• Nature Biomedical Engineering(18.952, 25.671, 29.234, 28.1, 26.8)(99.6%)
• Nature Computational Science (-, -, -, 11.3, 12.0)(99.1%)(ESCI)

Bimonthly press

• iMeta (-, -, -, -, 23.7)(99.1%)**(ESCI)
• Briefings in Bioinformatics (8.990, 11.622, 13.994, 9.5, 6.8)(95.9%)**
• GigaScience (5.993, 6.524, 7.658, 9.2, 11.8)(92.9%)**
• mSystems (6.633, 6.496, 7.331, 6.4, 5.0)(82.3%)

Email alert

• PLoS Biology (7.067, 8.029, 9.593, 9.8, 7.8)(95.9%)
• PLoS Computational Biology (4.700, 4.475, 4.779, 4.3, 3.8)(83.8%)
• bioRxiv Preprint server for Biology
• medRxiv Preprint server for Health Science

Other Journals

- Cancer, Medicine

• Journal of the National Cancer Institute(11.577, 13.506, 11.816, 10.3, 9.9)(91.5%)
• Journal of Experimental & Clinical Cancer Research(7.068, 11.161, 12.658, 11.3, 11.4)(92.4%) Italy
• eBioMedicine(5.730, 8.143, 11.205, 11.1, 9.7)(93.9%)**
• EMBO Molecular Medicine(8.821, 12.237, 14.005, 11.1, 9.0)(92.3%)**
• Journal of Biomedical Science(5.762, 8.410, 12.771, 11.0, 9.0)(92.3%) Taiwan

- Omics, Bioinformatics

• GENOMICS PROTEOMICS & BIOINFORMATICS(7.051, 7.691, 6.409, 9.5, 11.5)(97.1%) China
• Bioinformatics (5.610, 6.937, 6.931, 5.8, 4.4)(90.0%)
• Scientific Data(5.941, 6.444, 8.501, 9.8, 5.8)(88.4%)
• NAR Genomics and Bioinformatics (-, -, -, 4.6, 4.0)(88.5%) (ESCI)
• iScience(4.447, 5.458, 6.107, 5.8, 4.6)(86.2%)
• BioData Mining(2.672, 2.522, 4.097, 4.5, 4.0)(88.5%)
• Protein Science(3.876, 6.725, 6.993, 8.0, 4.5)(75.9%)
• Computational and Structural Biotechnology Journal (6.018, 7.271, 6.155, 6.0, 4.4)(74.0%)

- Microbiome

• ISME Journal(9.180, 10.302, 11.217, 11.0, 10.8)(98.2%)
• International Journal of Oral Science (3.047, 6.044, 29.897, 14.9, 10.8)(99.0%)**
• Clinical and Molecular Hepatology(3.987, 6.064, 8.337, 8.9, 14.0)(96.2%) Korea

- Multidisciplinary

• PNAS, Proceedings of the national academy of science of the USA (9.412, 11.250, 12.779, 11.1, 9.4)(90.7%)
• Research (-, -, 11.036, 11.0, 8.5)(89.8%)
• Communications Biology(4.165, 6.268, 6.548, 5.9, 5.2)(88.5%)
• Animal Cells and Systems(-, -, 2.398, 2.9, 2.5)(92.5%) Korea

Citation DB

-Impact Factor Search

• Journal Citation Reports
• Impact Factor Search
• SciVal Visualize research performance, benchmark relative to peers, develop strategic partnerships, identify and analyze new, emerging research trends, and create uniquely tailored reports